Trial intelligence / Profile preview

Efficacy of memantine in the treatment of fibromyalgia: 3‑month open exploratory study

2011-000802-23Phase 2Active

Sponsor
Javier García Campayo
Start
Nov 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of memantine in fibromyalgia (FM), sponsored by Javier García Campayo. Primary endpoints: Change in brain glutamate levels and Change in pain intensity. Started Nov 2011; status: active.

02

Drugs

memantine
03

Conditions

fibromyalgia (FM)

Beyond the preview

Go deeper on 2011-000802-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-000802-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call